Tnib Tablet works by blocking the action of some chemicals which cause inflammation. It can help reduce pain, stiffness, and swelling in your joints and slow down the progression of bone and joint damage. This will help you do normal daily activities more easily and thus improve your quality of life.It is also used in the treatment of psoriasis.
1. Treatment for Psoriasis: Tnib Tablets contain tofacitinib, an oral Janus kinase (JAK) inhibitor used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
2. Anti-Inflammatory Action: Tofacitinib modulates the immune response by inhibiting JAK enzymes, leading to reduced inflammation associated with psoriasis.
1. Tofacitinib: The active ingredient in Tnib Tablets, belonging to the JAK inhibitor class, it targets specific enzymes involved in the immune response.
Warnings of Tnib Tablet:
1. Infections: Tofacitinib may increase the risk of serious infections. Patients should be monitored for signs of infection, and therapy may need to be interrupted if a serious infection develops.
2. Malignancies: There is an increased risk of certain cancers, including lymphoma and skin cancers. Regular monitoring is essential.
3. Blood Disorders: Tofacitinib may cause changes in blood cell counts; regular monitoring of blood counts is necessary.
Usage of Tnib Tablet:
1. Prescription Only: Tnib Tablets are prescription medications and should be used under the supervision of a qualified healthcare professional.
2. Individualised Dosage: Dosage and duration are determined based on the severity of psoriasis and individual response. The healthcare provider will prescribe the appropriate dosage.
Side Effects of Tnib Tablet:
1. Infections: Increased susceptibility to infections, including respiratory and skin infections.
2. Gastrointestinal Issues: Common side effects may include diarrhoea, nausea, and abdominal discomfort.
3. Liver Function: Tofacitinib may affect liver function, and liver enzyme levels should be monitored regularly.
4. Blood Pressure Changes: Blood pressure should be monitored due to potential increases.
Safety Information of Tnib Tablet:
1. Pregnancy and Breastfeeding: Tofacitinib may have risks during pregnancy, and its use is generally not recommended during breastfeeding.
2. Vaccinations: Live vaccines should be avoided during treatment with tofacitinib.
3. Hepatitis B Screening: Patients should be screened for hepatitis B prior to starting treatment.
Note: It is essential to read and follow the instructions provided with the specific brand or formulation of Tnib Tablets and consult a dermatologist or healthcare professional for personalised advice regarding its use in dermatology.
Marketer details
Name: Micro Labs Ltd
Address: 27, RACE COURSE ROAD, BANGALORE-560 001, INDIA
Country of origin: IndiA.
Expires on or after: April, 2026
Facebook